In this episode of DeviceTalks Weekly, we visit with Claire Biot, vice president, life sciences at Dassault Systèmes to learn about the company’s virtual twin platform. Biot explains how the company is able to establish a digital model of a product requiring testing or patients who would serve as the test subject. The key benefits include faster product development, lower costs, higher sustainability, and stronger ethics. The company’s highest profile project might the Living Heart Project, which serves as a virtual twin of the living heart allowing for faster and safer testing of cardiac devices. Dassault Systèmes is working with the FDA to develop a method for testing. We’ll also connect with Jithesh Veetil, PhD, senior program director, Digital Health & Technology, at the Medical Device Innovation Consortium (MDIC). Veetil will explain how industry can incorporate virtual twin technology into development and testing. Here is a link to the Landscape Report & Industry Survey on the Use of Computational Modeling & Simulation in Medical Device Development.

https://mdic.org/wp-content/uploads/2023/01/CMS_Landscape_Report.pdf

This episode was sponsored by Dassault Systèmes.

Chris Newsmaker, executive editor of life sciences, also delivers his -award-winning-worthy Newmarker’s Newsmakers featuring news from Intuitive, Neuromod Devices, LivaNova, Johnson & Johnson Medtech and Medtronic.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

How Dassault Systèmes virtual twin platform promises real success to device developers

In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.

Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.

Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.

Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com

How Dassault Systèmes virtual twin platform promises real success to device developers

DeviceTalks

Related tracks